Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Biomarker Assessment of Adipose Derived Stem Cells and Fibroblasts in Patients With and Without Pelvic Organ Prolapse

NCT03642054 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03642054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Biomarker Assessment of Adipose Derived Stem Cells and Fibroblasts in Patients With and Without Pelvic Organ Prolapse
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
June 29, 2018
Completion date
May 18, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse